This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Industrial Farmaceutica Cantabria, S.a.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Jose Antonio Matji Tuduri: Innovator in Pharmacologically Active Glycoconjugates
Introduction
Jose Antonio Matji Tuduri is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmacology through his innovative work on glycopeptidic glycoconjugates. His research focuses on developing immunomodulating drugs that have the potential to control the production of tumor necrosis factor (TNF).
Latest Patents
Jose Antonio Matji Tuduri holds a patent for "Pharmacologically active polypeptide glycoconjugates." This invention relates to glycopeptidic glycoconjugates, where the polysaccharide is derived from cells and the peptides are obtained from seeds. The glycoconjugates are utilized in the preparation of drugs aimed at modulating immune responses.
Career Highlights
He is currently associated with Industrial Farmaceutica Cantabria, S.A., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in treating various medical conditions.
Collaborations
Some of his notable coworkers include Juan Pablo Pivel Raniert and Antonio Guerrero Gomez-Pamo. Their collaborative efforts contribute to the innovative environment at Industrial Farmaceutica Cantabria.
Conclusion
Jose Antonio Matji Tuduri's work in pharmacologically active glycoconjugates exemplifies the impact of innovation in the pharmaceutical industry. His contributions are paving the way for new therapeutic options in immunomodulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile